Making Insulin Affordable and Accessible for Everyone
Over 463 million people globally battle diabetes, with numbers expected to surge to 700 million by 2045. The essential treatment? Insulin. Yet, it remains out of reach for many due to high costs and complex production methods. Traditional insulin manufacturing is not only costly but also environmentally detrimental.
Plansulin: A groundbreaking solution designed to make insulin affordable and accessible through innovative plant-based production. Our method reduces costs by up to 40%, decreases environmental impact, and scales up to meet global demand.
Why now?
Global healthcare spends over 10% annually on diabetes treatment.
High insulin prices impair disease management, risking severe complications
Global diabetes prevalence and insulin affordability disparities.